Using a randomized crossover trial design , in a pilot study we compared @ days of IV tobramycin with nebulized tobramycin @mg twice a day ( TNS ) in acute respiratory exacerbations in @ CF adults chronically infected with Pseudomonas aeruginosa ( Psa ) .